China Medicine Corporation (OTC Bulletin Board: CHME) a developer and leading distributor of prescription and over the counter pharmaceuticals, traditional Chinese medicines, nutritional and dietary supplements, and medical devices and medical formulations, recently shared that Richard P. Wu has resigned as Chief Financial Officer of China Medicine in order to pursue other professional interests. His resignation was effective December 15, 2009. Mr. Robert Lu was appointed to serve as China Medicine Interim Chief Financial Officer until selected a permanent Chief Financial Officer.
Open Water Investments is a online financial portal focusing on the small cap and micro cap markets.
Sign Up for our Free Newsletter
Open Water Investments offers a free penny stock newsletter to members; the newsletter provides stock alerts exciting growth companies.
Robert Lu has served as China Medical's Financial Manager since August 6, 2009. Prior to joining the Company, Mr. Lu served as the International Regional Tax Manager of Hua Wei Technologies Co., Ltd. from October 2006 through August 2009. From August 2003 to September 2006, Mr. Lu served as a financial supervisor for Dongguan Pulse Electronics Co., Ltd. Mr. Lu received his Bachelor's degree in accounting from the Harbin Institute of Technology in 2003. Mr. Lu is a member of the Chinese Institute of Certified Public Accountants (CICPA) and is fluent in English. He will be supported by Ms. Huizhen Yu, the Company's controller. "We wish Mr. Wu well in his future endeavors and expect a smooth transition of his responsibilities to Mr. Lu, who has been involved with our cash planning, internal and external reporting and tax planning and capital budgeting for the last several months. We will seek to improve our financial management team with a permanent CFO in the months ahead," stated Mr. Senshan Yang, Chairman and CEO of China Medicine Corporation. China Corporation is a developer and leading distributor of prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. China Medicine also has its research and development force for certain products it manufactures through OEM arrangement makes the distribution. The Company distributes its products to wholesale distributors including more than 300 hospitals and 500 medicine companies that sell to over 2,000 drug stores in 28 provinces throughout China. China Medicine actively develops a number of proprietary products for a variety of uses, including oncology, high blood pressure and the removal of toxins from food and animal feeds.
Click Here to receive Open Water Investments' Penny Stock Newsletter for FREE. Investors interested in receiving small cap stock alerts through the penny stock newsletter published by Open Water Investments can also sign up for free in the frame at the bottom of this page.
About Us
Open Water Investments is a leading penny stock web site with experience in the over the counter markets, providing stock alerts, picks and exclusive research on small cap stocks.
Please click here to read our full disclaimer.
